Stockreport

KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting [Yahoo! Finance]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF – Additional safety data reinforces flexibility of dosing - CAMBRIDGE, Mass. & SALISBURY, England, February 26, 2024 BUSINESS WIRE )--KalVista Pharmaceuticals, Inc. ( [Read more]